Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Cns Pharmaceuticals
(BE5.F) Q4 2024
Earnings
BE5.F
Nov 14
Confirmed
Q4 2024
-11.87
-9.5
-7.12
-4.75
Details
Expected EPS
-4.7482999999999995
Actual EPS
-11.87075
Surprise EPS
-7.12
Surprise Percent
-150%
Description
Cns Pharmaceuticals (BE5.F) has reported earnings of -11.87075 per share for Q4 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login